CTIS.eu › Cities › Germany › Tuebingen
Tuebingen
Germany
591 total trials
259 recruiting
2025-523510-87-00
5
Obesity
2025-523558-14-00
1
Alpha-1 Antitrypsin Deficiency
2025-523630-59-00
9
colon carcinoma metastases
2025-523704-77-00
4
Geographic atrophy secondary to age-related macular degeneration
2025-523869-22-00
5
advanced or metastatic extrapulmonary neuroendocrine carcinoma
2025-524386-24-00
5
Head and neck cancer
2025-524435-39-00
4
Localized Scleroderma
2026-525349-65-00
4
Diabetic Retinopathy
2025-522001-38-00
4
2026-05-27
Crohn’s Disease
2023-503766-24-00
11
2026-05-26
Moderate to Severe Plaque Psoriasis
2025-523404-74-00
4
2026-05-26
Prurigo Nodularis
2025-521903-28-00
5
2026-05-06
Adenovirus viremia
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
2024-519830-22-00
5
2026-04-27
Heart failure due to systemic left ventricular systolic dysfunction
2025-522484-15-00
5
2026-04-27
ER+/HER2- early breast cancer
2025-523229-16-00
4
2026-04-27
locally advanced basal cell carcinoma patients
2025-523230-77-00
4
2026-04-27
Patients with locally advanced Basal Cell Carcinoma (LaBCC) amenable t
2025-523231-19-00
4
2026-04-27
Cutaneous Squamous Cell Carcinoma
2025-523100-77-00
4
2026-04-23
Ulcerative Colitis
2025-522878-36-00
5
2026-04-20
Chronic Spontaneous Urticaria
2024-512248-47-00
9
2026-04-15
Non-small Cell Lung Cancer (NSCLC)
2025-522387-32-00
5
2026-04-10
Uveal Melanoma
2025-523013-28-00
4
2026-04-07
Endocrine-Resistant Hormone-Receptor-Positive, HER2-Negative Advanced
2025-522279-27-00
5
2026-04-02
Newly Diagnosed AML with an NPM1 mutation
Showing 25–48 of 591 trials